ATI LPN
ATI Mental Health Practice A 2023
1. A patient with anorexia nervosa is being treated in an inpatient facility. Which intervention should be included in the care plan?
- A. Allowing the patient to eat alone to reduce stress
- B. Monitoring the patient's weight weekly
- C. Encouraging the patient to exercise daily
- D. Providing the patient with a high-calorie diet
Correct answer: B
Rationale: Monitoring the patient's weight weekly is crucial in the care of individuals with anorexia nervosa as it allows healthcare providers to track changes in weight, which is a key indicator of nutritional status. Regular weight monitoring helps in identifying any significant weight loss or gain, enabling prompt intervention and adjustment of the treatment plan to address the patient's nutritional needs effectively.
2. During the working phase of a therapeutic relationship, a client with methamphetamine use disorder displays transference behavior. Which action by the client indicates transference behavior?
- A. The client asks the nurse if they will go out to dinner together
- B. The client accuses the nurse of being controlling just like an ex-partner
- C. The client reminds the nurse of a friend who died from substance toxicity
- D. The client becomes angry and threatens to engage in self-harm
Correct answer: B
Rationale: Transference occurs when a client projects feelings, often unconscious, onto the nurse that are associated with significant figures in their past or present life. In this scenario, the client accusing the nurse of being controlling like an ex-partner demonstrates transference behavior by attributing characteristics of someone from their past onto the nurse. Choices A, C, and D do not reflect transference behavior. Choice A involves a social invitation, which is not necessarily transference. Choice C is more related to countertransference as it triggers memories in the nurse, not the client. Choice D describes aggressive behavior and self-harm threats, which are not indicative of transference.
3. A healthcare provider is educating a patient about the side effects of selective serotonin reuptake inhibitors (SSRIs). Which side effect should the provider emphasize?
- A. Weight gain
- B. Increased libido
- C. Nausea
- D. Insomnia
Correct answer: C
Rationale: When educating patients about SSRIs, it is crucial to emphasize the common side effect of nausea. Nausea is a frequently reported side effect of SSRIs that can impact adherence to treatment. By highlighting this side effect, patients can be better prepared and informed about what to expect when taking these medications. Choices A, B, and D are incorrect as weight gain, increased libido, and insomnia are not typically associated with SSRIs as common side effects. Nausea is a more relevant and prevalent side effect to address with patients.
4. Which medication is commonly used to treat both major depressive disorder and neuropathic pain?
- A. Gabapentin
- B. Duloxetine
- C. Amitriptyline
- D. Tramadol
Correct answer: B
Rationale: Duloxetine, also known as Cymbalta, is a medication commonly used to treat both major depressive disorder and neuropathic pain. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that helps alleviate symptoms associated with these conditions. Gabapentin is primarily used for neuropathic pain, Amitriptyline is commonly used as an antidepressant, and Tramadol is an opioid analgesic often used for pain relief but not typically indicated for major depressive disorder.
5. A patient is receiving education about taking clozapine. Which statement indicates the patient understands the side effects?
- A. I should report any signs of infection to my healthcare provider immediately.
- B. I can stop taking this medication once I feel better.
- C. I should take this medication on an empty stomach.
- D. I should avoid drinking alcohol while taking this medication.
Correct answer: A
Rationale: The correct answer is A because patients taking clozapine should report signs of infection immediately due to the risk of agranulocytosis. Agranulocytosis is a potentially life-threatening side effect of clozapine characterized by a significant decrease in white blood cell count, which can leave the patient vulnerable to infections. Reporting signs of infection promptly is crucial to prevent serious complications.
Similar Questions
Access More Features
ATI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access